These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
666 related articles for article (PubMed ID: 26167071)
21. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers. Venerito M; Malfertheiner P Helicobacter; 2010 Aug; 15(4):239-50. PubMed ID: 20633184 [TBL] [Abstract][Full Text] [Related]
22. Nonsteroidal antiinflammatory drug-induced mucosal lesions of the upper gastrointestinal tract and their relationship to Helicobacter pylori. Rybár I; Masaryk P; Mateicka F; Kopecký S; Rovenský J Int J Clin Pharmacol Res; 2001; 21(3-4):119-25. PubMed ID: 12067141 [TBL] [Abstract][Full Text] [Related]
23. Factors associated with gastro-duodenal disease in patients undergoing upper GI endoscopy at the Korle-Bu Teaching Hospital, Accra, Ghana. Archampong TN; Asmah RH; Wiredu EK; Gyasi RK; Nkrumah KN Afr Health Sci; 2016 Jun; 16(2):611-9. PubMed ID: 27605979 [TBL] [Abstract][Full Text] [Related]
24. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease. Kato S; Nishino Y; Ozawa K; Konno M; Maisawa S; Toyoda S; Tajiri H; Ida S; Fujisawa T; Iinuma K J Gastroenterol; 2004 Aug; 39(8):734-8. PubMed ID: 15338366 [TBL] [Abstract][Full Text] [Related]
25. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Van der Hulst RW; Rauws EA; Köycü B; Keller JJ; Bruno MJ; Tijssen JG; Tytgat GN Gastroenterology; 1997 Oct; 113(4):1082-6. PubMed ID: 9322501 [TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa. Wex T; Ye S; Treiber G; Vieth M; Roessner A; Malfertheiner P Helicobacter; 2006 Feb; 11(1):31-8. PubMed ID: 16423087 [TBL] [Abstract][Full Text] [Related]
27. Short-term/low-dose aspirin-induced duodenal erosions are not dependent on Helicobacter pylori infection, cyclooxygenase expression and prostaglandin E2 levels. Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Mönkemüller K; Malfertheiner P Scand J Gastroenterol; 2008; 43(7):801-9. PubMed ID: 18584518 [TBL] [Abstract][Full Text] [Related]
28. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. Musumba C; Jorgensen A; Sutton L; Van Eker D; Moorcroft J; Hopkins M; Pritchard DM; Pirmohamed M Aliment Pharmacol Ther; 2012 Jul; 36(1):48-56. PubMed ID: 22554233 [TBL] [Abstract][Full Text] [Related]
29. Helicobacter pylori infection as a risk factor for gastric ulceration. Mitani K; Tatsuta M; Iishi H; Yano H; Uedo N; Iseki K; Narahara H Hepatogastroenterology; 2004; 51(55):309-12. PubMed ID: 15011891 [TBL] [Abstract][Full Text] [Related]
30. Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid? Kordecki H; Kurowski M; Kosik R; Pilecka D J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():85-91. PubMed ID: 9440059 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of Helicobacter pylori in southern Indian controls and patients with gastroduodenal disease. Prasad S; Mathan M; Chandy G; Rajan DP; Venkateswaran S; Ramakrishna BS; Mathan VI J Gastroenterol Hepatol; 1994; 9(5):501-6. PubMed ID: 7827302 [TBL] [Abstract][Full Text] [Related]
32. Risk and preventive factors of low-dose aspirin-induced gastroduodenal injuries: a comprehensive review. Shiotani A; Manabe N; Kamada T; Fujimura Y; Sakakibara T; Haruma K J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():8-12. PubMed ID: 22486865 [TBL] [Abstract][Full Text] [Related]
33. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?]. Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802 [TBL] [Abstract][Full Text] [Related]
34. Endoscopic survey of low-dose-aspirin-induced gastroduodenal mucosal injuries in patients with ischemic heart disease. Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S234-6. PubMed ID: 19120904 [TBL] [Abstract][Full Text] [Related]
35. Duodenal and gastric cell regenerating epithelia on margins of human duodenal ulcer and presence of H. pylori--an electron microscopic study. Ogata T Histol Histopathol; 1997 Jan; 12(1):57-68. PubMed ID: 9046044 [TBL] [Abstract][Full Text] [Related]
36. How closely is Helicobacter pylori infection related to gastroduodenal lesions? Shimamoto C; Hirata I; Tokioka S; Takeuchi N; Hiraike Y; Katsu K Hepatogastroenterology; 2006; 53(71):804-6. PubMed ID: 17086893 [TBL] [Abstract][Full Text] [Related]
38. [Helicobacter pylori, nonsteroidal anti-inflammatory agents and gastroduodenal changes]. Teixeira AV Acta Med Port; 1995 Sep; 8(9):517-21. PubMed ID: 7484272 [TBL] [Abstract][Full Text] [Related]
39. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals. Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106 [TBL] [Abstract][Full Text] [Related]
40. High Serum Pepsinogen I and beta Helicobacter pylori Infection Are Risk Factors for Aspirin-Induced Gastroduodenal Injury. Shan J; Lei H; Shi W; Sun X; Tang Y; Ren C Dig Dis; 2018; 36(1):66-71. PubMed ID: 28595197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]